---
figid: PMC5216829__oncotarget-07-46678-g001
figlink: /pmc/articles/PMC5216829/figure/F1/
number: F1
caption: 'The mechanisms of action of the three anti-angiogenic drugs (bevacizumab,
  aflibercept and regorafenib) commonly used in mCRC treatment are shown in the lower
  part of the figure. Hypoxia inhibits the activity of PHD enzymes, allowing HIF-1α
  proteins to be stabilized, to dimerize with HIF-1β and to translocate to the nucleus.
  This complex binds hypoxia response elements (HREs) within the promoters of target
  genes. HIF-target genes are involved in cell growth and survival, proliferation,
  metabolic reprogramming, apoptosis and induction of angiogenesis mediated by vascular
  endothelial growth factor and angiopoietins. HIF-1α may also be upregulated in tumor
  cells by the activation of the PI3K-AKT-mTOR pathway. VEGF family members and angiopoietins
  interact with their receptors (VEGFR-1,-2,-3, NP1/2, Tie2), leading to different
  biological consequences. HIF: hypoxia-inducible factor; PHD: prolyl hydroxylase;
  HRE: hypoxia response element; PlGF: placenta growth factor; VEGF: vascular endothelial
  growth factor; VEGFR: vascular endothelial growth factor receptor; NP: neuropilin;
  Ang: angiopoietin.'
pmcid: PMC5216829
papertitle: Relationship between hypoxia and response to antiangiogenic therapy in
  metastatic colorectal cancer.
reftext: Paola Ulivi, et al. Oncotarget. 2016 Jul 19;7(29):46678-46691.
pmc_ranked_result_index: '29588'
pathway_score: 0.862089
filename: oncotarget-07-46678-g001.jpg
figtitle: Relationship between hypoxia and response to antiangiogenic therapy in metastatic
  colorectal cancer
year: '2016'
organisms: Homo sapiens
ndex: 5131f53c-df1f-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5216829__oncotarget-07-46678-g001.html
  '@type': Dataset
  description: 'The mechanisms of action of the three anti-angiogenic drugs (bevacizumab,
    aflibercept and regorafenib) commonly used in mCRC treatment are shown in the
    lower part of the figure. Hypoxia inhibits the activity of PHD enzymes, allowing
    HIF-1α proteins to be stabilized, to dimerize with HIF-1β and to translocate to
    the nucleus. This complex binds hypoxia response elements (HREs) within the promoters
    of target genes. HIF-target genes are involved in cell growth and survival, proliferation,
    metabolic reprogramming, apoptosis and induction of angiogenesis mediated by vascular
    endothelial growth factor and angiopoietins. HIF-1α may also be upregulated in
    tumor cells by the activation of the PI3K-AKT-mTOR pathway. VEGF family members
    and angiopoietins interact with their receptors (VEGFR-1,-2,-3, NP1/2, Tie2),
    leading to different biological consequences. HIF: hypoxia-inducible factor; PHD:
    prolyl hydroxylase; HRE: hypoxia response element; PlGF: placenta growth factor;
    VEGF: vascular endothelial growth factor; VEGFR: vascular endothelial growth factor
    receptor; NP: neuropilin; Ang: angiopoietin.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PTEN
  - KDR
  - PIK3CB
  - PIGF
  - FLT1
  - VEGFD
  - PIK3R5
  - PIK3R4
  - PIK3CA
  - VEGFA
  - PIK3R6
  - NRAS
  - PIK3R3
  - FLT4
  - EPAS1
  - RET
  - TEK
  - BRAF
  - VEGFB
  - VEGFC
  - PIK3CG
  - FGFR3
  - FGFR2
  - FGFR4
  - FGFRL1
  - ARNT2
  - HIF3A
  - PDGFRB
  - PDGFRA
  - AKT3
  - AKT1
  - FGFR1
  - HRAS
  - KRAS
  - PGF
  - RAF1
  - AKT2
  - ARAF
  - KIT
  - PIK3CD
  - ARNT
  - HIF1A
  - MTOR
  - ARNTL
  - Regorafenib
  - Cancer
  - Lung cancer
genes:
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: VEGFR2
  symbol: VEGFR2
  source: hgnc_alias_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PIGF
  symbol: PIGF
  source: hgnc_symbol
  hgnc_symbol: PIGF
  entrez: '5281'
- word: VEGFR1
  symbol: VEGFR1
  source: hgnc_alias_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: VEGF-A
  symbol: VEGF-A
  source: hgnc_alias_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: VEGF-D
  symbol: VEGF-D
  source: hgnc_alias_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: VEGFR3
  symbol: VEGFR3
  source: hgnc_alias_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: EPAS1
  entrez: '2034'
- word: RET,
  symbol: RET
  source: hgnc_symbol
  hgnc_symbol: RET
  entrez: '5979'
- word: Tie2
  symbol: TIE-2
  source: hgnc_alias_symbol
  hgnc_symbol: TEK
  entrez: '7010'
- word: RAF,BRAF,RET,KIT,PDGFR,FGFR
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: VEGF-B
  symbol: VEGFB
  source: hgnc_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF-C
  symbol: VEGFC
  source: hgnc_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR4
  entrez: '2264'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFRL1
  entrez: '53834'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT2
  entrez: '9915'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF3A
  entrez: '64344'
- word: RAF,BRAF,RET,KIT,PDGFR,FGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: RAF,BRAF,RET,KIT,PDGFR,FGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
- word: RAF,BRAF,RET,KIT,PDGFR,FGFR
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: RAF,BRAF,RET,KIT,PDGFR,FGFR
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: RAF,BRAF,RET,KIT,PDGFR,FGFR
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: KIT,
  symbol: KIT
  source: hgnc_symbol
  hgnc_symbol: KIT
  entrez: '3815'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT
  entrez: '405'
- word: HIF-1B
  symbol: HIF-1beta
  source: hgnc_alias_symbol
  hgnc_symbol: ARNT
  entrez: '405'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: HIF-1a
  symbol: HIF-1alpha
  source: hgnc_alias_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNTL
  entrez: '406'
chemicals:
- word: Regorafenib
  source: MESH
  identifier: C559147
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
figid_alias: PMC5216829__F1
redirect_from: /figures/PMC5216829__F1
figtype: Figure
---
